- Home
- IAE vs LNSR Comparison
IAE vs LNSR Comparison
Compare IAE & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
IAE
Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Current Price
Company Overview
Basic Information| Metric | IAE | LNSR |
|---|---|---|
| Founded | 2007 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical Electronics |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.0M | 106.6M |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | IAE | LNSR |
|---|---|---|
| Price | $8.74 | $7.05 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 24.5K | ★ 89.5K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | ★ 10.21% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $58,435,000.00 |
| Revenue This Year | N/A | $10.06 |
| Revenue Next Year | N/A | $41.48 |
| P/E Ratio | ★ N/A | $11.62 |
| Revenue Growth | N/A | ★ 9.24 |
| 52 Week Low | $7.04 | $4.95 |
| 52 Week High | $9.27 | $12.94 |
Technical Indicators
Market Signals| Indicator | IAE | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 49.16 | 38.71 |
| Support Level | $8.11 | $5.17 |
| Resistance Level | $8.90 | $8.73 |
| Average True Range (ATR) | 0.15 | 0.36 |
| MACD | -0.03 | -0.26 |
| Stochastic Oscillator | 49.15 | 4.37 |
Price Performance
Historical ComparisonAbout IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.
About LNSR LENSAR Inc.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.